indazoles has been researched along with Hemangioendothelioma, Epithelioid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basturk, O; Corrias, G; Giancipoli, RG; Keohan, ML; Klimstra, D; Mannelli, L; Monti, S; Sawan, P; Schillaci, O | 1 |
| Bar-Sela, G; Keidar, Z; Naroditsky, I; Semenisty, V | 1 |
| Duffaud, F; Gelderblom, H; Grignani, G; Gronchi, A; Guida, M; Jones, RL; Kasper, B; Katz, D; Kollár, A; Litière, S; Marreaud, S; Safwat, A; Sleijfer, S; Stacchiotti, S; Steeghs, N; Touati, N; van der Graaf, WT | 1 |
1 review(s) available for indazoles and Hemangioendothelioma, Epithelioid
| Article | Year |
|---|---|
Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Female; Hemangioendothelioma, Epithelioid; Humans; Immunohistochemistry; Indazoles; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
1 trial(s) available for indazoles and Hemangioendothelioma, Epithelioid
| Article | Year |
|---|---|
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Female; Follow-Up Studies; Hemangioendothelioma, Epithelioid; Hemangiosarcoma; Humans; Indazoles; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms; Prognosis; Pyrimidines; Retrospective Studies; Sulfonamides; Survival Rate; Tunica Intima | 2017 |
1 other study(ies) available for indazoles and Hemangioendothelioma, Epithelioid
| Article | Year |
|---|---|
Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Indazoles; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Pyrimidines; Radiopharmaceuticals; Sulfonamides; Treatment Outcome | 2018 |